| [1] |
Pantel K,Alix-Panabières C.Circulating tumour cells in cancer patients:challenges and perspectives[J].Trends Mol Med,2010,16(9):398-406.
|
| [2] |
Dotan E,Cohen SJ,Alpaugh KR,et al.Circulating tumor cells:evolving evidence and future challenges[J].Oncologist,2009,14(11):1070-82.
|
| [3] |
Zhao S,Liu Y,Zhang Q,et al.The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR inbreast cancer:a meta-analysis of published literature[J].Breast Cancer Res Treat,2011,130(3):809-16.
|
| [4] |
Rahbari NN,Aigner M,Thorlund K,et al.Meta-analysis shows that detection of circulating tumor cells indicatespoor prognosis in patients with colorectal cancer[J].Gastroenterology,2010,138(5):1714-26.
|
| [5] |
Stroup DF,Berlin JA,Morton SC,et al.Meta -analysis of observational studies in epidemiology:a proposal forreporting.Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group [J].JAMA,2000,283(15):2008-12.
|
| [6] |
Parmar MK,Torri V,Stewart L.Extracting summary statistics to perform meta-analyses of the publishedliterature for survival endpoints[J].Stat Med,1998,17(24):2815-34.
|
| [7] |
Majima T,Ichikura T,Takayama E,et al.Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for cytokeratin mRNA in peripheral blood from patients with gastric cancer[J].Jpn JClin Oncol,2000,30(11):499-503.
|
| [8] |
Nishida S,Kitamura K,Ichikawa D,et al.Molecular detection of disseminated cancer cells in the peripheralblood of patients with gastric cancer[J].Anticancer Res,2000,20(3B):2155-9.
|
| [9] |
Miyazono F,Natsugoe S,Takao S,et al.Surgical maneuvers enhance molecular detection of circulating tumorcells during gastric cancer surgery[J].Ann Surg,2001,233(2):189-94.
|
| [10] |
Shin JH,Chung J,Kim HO,et al.Detection of cancer cells in peripheral blood of stomach cancer patients usingRT-PCR amplification of tumour-specific mRNAs[J].Aliment Pharmacol Ther,2002,16(Suppl 2):137-44.
|
| [11] |
Sumikura S,Ishigami S,Natsugoe S,et al.Disseminated cancer cells in the blood and expression of sialylatedantigen in gastric cance[J].Cancer Lett,2003,200(1):77-83.
|
| [12] |
Seo JH,Choi CW,Kim BS,et al.Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reversetranscription-polymerase chain reaction as an early marker of clinical recurrence in patients with curativelyresected gastric cancer[J].Am J Clin Oncol,2005,28(1):24-9.
|
| [13] |
Illert B,Fein M,Otto C,et al.Disseminated tumor cells in the blood of patients with gastric cancer are anindependent predictive marker of poor prognosis[J].Scand J Gastroenterol,2005,40(7):843-9.
|
| [14] |
Ikeguchi M,Kaibara N.Detection of circulating cancer cells after a gastrectomy for gastric cancer[J].SurgToday,2005,35(6):436-41.
|
| [15] |
Wu CH,Lin SR,Hsieh JS,et al.Molecular detection of disseminated tumor cells in the peripheral blood ofpatients with gastric cancer:evaluation of their prognostic significance[J].Dis Markers,2006,22(3):103-9.
|
| [16] |
Uen YH,Lin SR,Wu CH,et al.Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumorcells in patients with gastric carcinoma[J].Clin Chim Acta,2006,367(1-2):55-61.
|
| [17] |
Kosaka Y,Mimori K,Fukagawa T,et al.Identification of the high-risk group for metastasis of gastric cancercases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood[J].Br JCancer,2007,96(11):1723-8.
|
| [18] |
Koga T,Tokunaga E,Sumiyoshi Y,et al.Detection of circulating gastric cancer cells in peripheral blood usingreal time quantitative RT-PCR[J].Hepatogastroenterology,2008,55(84):1131-5.
|
| [19] |
Yie SM,Lou B,Ye SR,et al.Detection of surviving-expressing circulating cancer cells (CCCs) in peripheralblood of patients with gastric and colorectal cancer reveals high risks of relapse[J].Ann Surg Oncol,2008,15(11):3073-82.
|
| [20] |
Bertazza L,Mocellin S,Marchet A,et al.Survivin gene levels in the peripheral blood of patients with gastriccancer independently predict survival[J].J Transl Med,2009,7:111.
|
| [21] |
Kita Y,Fukagawa T,Mimori K,et al.Expression of uPAR mRNA in peripheral blood is a favourite marker formetastasis in gastric cancer cases[J].Br J Cancer,2009,100(1):153-9.
|
| [22] |
Qiu MZ,Li ZH,Zhou ZW,et al.Detection of carcinoembryonic antigen messenger RNA in blood using quantitativereal-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinoma[J].JTransl Med,2010,8:107.
|
| [23] |
Arigami T,Uenosono Y,Hirata M,et al.B7-H3 expression in gastric cancer:a novel molecular blood marker fordetecting circulating tumor cells[J].Cancer Sci,2011,102(5):1019-24.
|
| [24] |
Cao W,Yang W,Li H,et al.Using detection of surviving-expressing circulating tumor cells in peripheral bloodto predict tumor recurrence following curative resection of gastric cancer[J].J Surg Oncol,2011,103(2):110-5.
|
| [25] |
Kutun S,Celik A,Cem Kockar M,et al.Expression of CK-19 and CEA mRNA in peripheral blood of gastric cancerpatients[J].Exp Oncol,2010,32(4):263-8.
|
| [26] |
Mocellin S,Keilholz U,Rossi CR,et al.Circulating tumor cells:the ‘leukemic phase’ of solid cancers[J].Trends Mol Med,2006,12(3):130-9.
|
| [27] |
Bidard FC,Mathiot C,Delaloge S,et al.Single circulating tumor cell detection and overall survival innonmetastatic breast cancer[J].Ann Oncol,2010,21(4):729-33.
|
| [28] |
Van der Auwera I,Peeters D,Benoy IH,et al.Circulating tumour cell detection:a direct comparison between theCellSearch System,the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer[J].Br JCancer,2010,102(2):276-84.
|
下载:
